AU and AUH appoint new cancer researcher
Karina Dalsgaard Sørensen conducts research into prostate cancer. She has been appointed professor at Aarhus University and Aarhus University Hospital.
More than 4,000 men are annually diagnosed with prostate cancer. Karina Dalsgaard Sørensen's research targets the treatment of these men. Karina Dalsgaard Sørensen has just been appointed professor at AU and AUH, where she works with the molecular biological aspects of prostate cancer.
"One of the things we use are advanced DNA/RNA methods to analyse samples of tissue, blood and urine from patients with prostate cancer, so we can develop new and better methods for early diagnosis and distinguish between aggressive and non-aggressive diseases," says Karina Dalsgaard Sørensen.
She emphasises that the research is important for patients who either have or are suspected of having prostate cancer.
"New and improved diagnostics can improve the quality of treatment. With the professorship, we wish to pave the way for new molecular diagnostic methods that can ensure early and accurate detection of the disease and the right treatment for the individual patient," she says.
This is called precision medicine and can lead to a better understanding of the mechanisms that control how prostate cancer develops and spreads.
"This knowledge is crucial for our ability to develop new and more targeted treatment strategies," explains Karina Dalsgaard Sørensen.
Further information
Karina Dalsgaard Sørensen
Aarhus University, Department of Clinical Medicine and
Aarhus University Hospital, Department of Molecular Medicine
Direct tel.: (+45) 7845 5316
Email: kdso@clin.au.dk